Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
06/08/2026 07:35
BRIEF-Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million Aug 6 (Reuters) - Immunovia AB (publ) IMMNOV.ST:
Q2 ADJUSTED EPS SEK -0.03
Q2 NET SALES OF 381 KSEK, PRIMARILY FROM PANCREASURE TESTS
Q2 OPERATING LOSS OF 22.8 MSEK
Source text: ID:nMFN76FxQL
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study